Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

NCT07149363 is registered in ClinicalTrials.gov with Alliance Foundation Trials, LLC. as lead sponsor.

NCT NCT07149363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07149363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Lead sponsor
Alliance Foundation Trials, LLC.
Phase
Phase 2
Overall status
Recruiting
Start date
February 12, 2026
Completion date
February 28, 2031
Enrollment
65 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer (sclc)